UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030290 |
|---|---|
| Receipt number | R000034585 |
| Scientific Title | Blood endotoxin levels in impaired glucose tolerance and diabetes: prospective study |
| Date of disclosure of the study information | 2017/12/07 |
| Last modified on | 2020/12/08 12:47:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Blood endotoxin levels in impaired glucose
tolerance and diabetes: prospective study
Acronym
Blood endotoxin levels and glucose metabolism
Scientific Title
Blood endotoxin levels in impaired glucose
tolerance and diabetes: prospective study
Scientific Title:Acronym
Blood endotoxin levels and glucose metabolism
Region
| Japan |
Condition
Condition
impaired glucose tolerance (IGT) and diabetes mellitus (DM)
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Comparison of blood endotoxin levels between at admission and discharge in treatment of diabetes.
Basic objectives2
Others
Basic objectives -Others
N/A
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Comparison of blood endotoxin levels between at admission and discharge in treatment of diabetes.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Impaired glucose tolerance and diabetes mellitus
Key exclusion criteria
1)Acute phase of infection
2)Digestive disease
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Hideki |
| Middle name | |
| Last name | Katagiri |
Organization
Tohoku University Hospital
Division name
Department of Daibetes and Metabolism
Zip code
980-8577
Address
Seiryo-machi 1-1, Aoba-ku, Sendai, Miyagi
TEL
022-717-7779
ssawada@med.tohoku.ac.jp
Public contact
Name of contact person
| 1st name | Shojiro |
| Middle name | |
| Last name | Sawada |
Organization
Tohoku University Hospital
Division name
Department of Daibetes and Metabolism
Zip code
980-8577
Address
Seiryo-machi 1-1, Aoba-ku, Sendai, Miyagi
TEL
022-717-7779
Homepage URL
ssawada@med.tohoku.ac.jp
Sponsor or person
Institute
Tohoku University Hospital
Institute
Department
Personal name
Funding Source
Organization
Tohoku University Hospital
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tohoku University Hospital
Address
Seiryo-machi 1-1, Aoba-ku, Sendai, Miyagi
Tel
022-717-7779
ssawada@med.tohoku.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 12 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 12 | Month | 06 | Day |
Date of IRB
| 2018 | Year | 05 | Month | 16 | Day |
Anticipated trial start date
| 2018 | Year | 01 | Month | 15 | Day |
Last follow-up date
| 2020 | Year | 12 | Month | 07 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
N/A
Management information
Registered date
| 2017 | Year | 12 | Month | 06 | Day |
Last modified on
| 2020 | Year | 12 | Month | 08 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034585
